Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 201 - 225 of 2,573

«
1
…
7
8
9
10
11
…
103
»

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Antibody Drug Conjugates: New Agents and Optimal Sequencing

By: Hope S. Rugo, MD, FASCO

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid A. Mayer, MD, MSCI

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid A. Mayer, MD, MSCI

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid Mayer, MD

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid Mayer, MD

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

By: Jane Lowe Meisel, MD

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

By: Jane Lowe Meisel, MD

ADC in Breast Cancer Management

ADC in Breast Cancer Management

By: Jane Lowe Meisel, MD

ADC in Breast Cancer Management

ADC in Breast Cancer Management

By: Jane Lowe Meisel, MD

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

By: Jane Meisel, MD

Advances in HER2 Positive Metastatic Breast Cancer

Advances in HER2 Positive Metastatic Breast Cancer

By: Janice Lu, MD, PhD

Radiation Theraphy and Genomic Interactions in Breast Cancer Patients

Radiation Theraphy and Genomic Interactions in Breast Cancer Patients

By: Javier F. Torres-Roca, MD

Triple Negative Breast Cancer

Triple Negative Breast Cancer

By: Jennifer R. Diamond, MD

Triple Negative Breast Cancer

Triple Negative Breast Cancer

By: Jennifer R. Diamond, MD

Advanced Breast Cancer: State of the Art

Advanced Breast Cancer: State of the Art

By: Joanne Mortimer, MD, FACP, FASCO

Advanced Breast Cancer: State of the Art

Advanced Breast Cancer: State of the Art

By: Joanne Mortimer, MD, FACP, FASCO

Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA

Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA

By: John T. Cole MD

Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA

Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA

By: John T. Cole MD

Updates on ER+ Breast Cancer

Updates on ER+ Breast Cancer

By: Joseph A. Sparano, MD, FACP

Updates on ER+ Breast Cancer

Updates on ER+ Breast Cancer

By: Joseph A. Sparano, MD, FACP

Challenges in Breast Cancer Immunotherapy

Challenges in Breast Cancer Immunotherapy

By: Joyce O'Shaughnessy, MD

Breast Cancer Immunotherapy

Breast Cancer Immunotherapy

By: Joyce O'Shaughnessy, MD

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

By: Joyce O’Shaughnessy, MD

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

By: Joyce O’Shaughnessy, MD

Immunotherapy in Breast Cancer

Immunotherapy in Breast Cancer

By: Joyce O’Shaughnessy, MD

«
1
…
7
8
9
10
11
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok